{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:39:24Z","timestamp":1767181164260,"version":"build-2238731810"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T00:00:00Z","timestamp":1402876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099967","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T21:29:22Z","timestamp":1402954162000},"page":"e99967","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["First Identification of Resident and Circulating Fibrocytes in Dupuytren\u2019s Disease Shown to Be Inhibited by Serum Amyloid P and Xiapex"],"prefix":"10.1371","volume":"9","author":[{"given":"Syed Amir","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael John","family":"Hayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Stewart","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Szczypa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeshir","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1308\/003588406X83104","article-title":"Management of Dupuytren\u2019s disease-clear advice for an elusive condition","volume":"88","author":"A Bayat","year":"2006","journal-title":"Annals of the Royal College of Surgeons of England"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11552-010-9306-4","article-title":"Prevalence, incidence, and treatments of Dupuytren\u2019s disease in the United States: results from a population-based study","volume":"6","author":"DB Dibenedetti","year":"2011","journal-title":"Hand (N Y)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","article-title":"Epidemiological evaluation of Dupuytren\u2019s disease incidence and prevalence rates in relation to etiology","volume":"4","author":"S Hindocha","year":"2009","journal-title":"Hand (N Y)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.12968\/hmed.2007.68.11.27683","article-title":"Assessment of clinical severity in Dupuytren\u2019s disease","volume":"68","author":"A Bayat","year":"2007","journal-title":"British journal of hospital medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease","volume":"6","author":"B Shih","year":"2010","journal-title":"Nature reviews Rheumatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrrheum.2009.255","article-title":"Connective tissue diseases: A nonsurgical therapy for Dupuytren disease","volume":"6","author":"A Bayat","year":"2010","journal-title":"Nature reviews Rheumatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/scd.2011.0140","article-title":"Identification of Mesenchymal Stem Cells in Perinodular Fat and Skin in Dupuytren\u2019s Disease: A Potential Source of Myofibroblasts with Implications for Pathogenesis and Therapy","volume":"21","author":"SA Iqbal","year":"2012","journal-title":"Stem cells and development"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0266-7681(93)90029-F","article-title":"The presence of myofibroblasts in the dermis of patients with Dupuytren\u2019s contracture. A possible source for recurrence","volume":"18","author":"BG McCann","year":"1993","journal-title":"J Hand Surg Br"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jhsa.2009.08.005","article-title":"Myofibroblast distribution in Dupuytren\u2019s cords: correlation with digital contracture","volume":"34","author":"LS Verjee","year":"2009","journal-title":"J Hand Surg Am"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jcp.1041170310","article-title":"Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren\u2019s disease","volume":"117","author":"B Azzarone","year":"1983","journal-title":"J Cell Physiol"},{"key":"ref11","first-page":"372","article-title":"The role of the skin in Dupuytren\u2019s disease","volume":"67","author":"J Hueston","year":"1985","journal-title":"Ann R Coll Surg Engl"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02537234","article-title":"Lipid composition and de novo lipid biosynthesis of human palmar fat in Dupuytren\u2019s disease","volume":"18","author":"JL Rabinowitz","year":"1983","journal-title":"Lipids"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/03008207.2012.686542","article-title":"Expression of MMP-2, TIMP-2, TGF-beta1, and decorin in Dupuytren\u2019s contracture","volume":"53","author":"K Ratajczak-Wielgomas","year":"2012","journal-title":"Connect Tissue Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"B Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.0309132","article-title":"The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis","volume":"86","author":"RM Strieter","year":"2009","journal-title":"J Leukoc Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-003-0517-9","article-title":"The role of epithelial-to-mesenchymal transition in renal fibrosis","volume":"82","author":"M Zeisberg","year":"2004","journal-title":"J Mol Med (Berl)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"R Bucala","year":"1994","journal-title":"Mol Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11926-000-0027-5","article-title":"Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis","volume":"2","author":"J Chesney","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.160.1.419","article-title":"Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes","volume":"160","author":"J Chesney","year":"1998","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e9730","DOI":"10.1371\/journal.pone.0009730","article-title":"Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum","volume":"5","author":"SJ Curnow","year":"2010","journal-title":"PloS one"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s004180050235","article-title":"Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo","volume":"109","author":"SJ Oh","year":"1998","journal-title":"Histochem Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-386035-4.00001-X","article-title":"Circulating fibrocytes-biology and mechanisms in wound healing and scar formation","volume":"291","author":"G Grieb","year":"2011","journal-title":"International review of cell and molecular biology"},{"key":"ref23","first-page":"5537","article-title":"Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol","volume":"171","author":"D Pilling","year":"2003"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/jmri.21800","article-title":"Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation","volume":"30","author":"V Vakil","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/BCR.0b013e31817db90a","article-title":"Are fibrocytes present in pediatric burn wounds?","volume":"29","author":"AJ Holland","year":"2008","journal-title":"J Burn Care Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1524-475X.2006.00192.x","article-title":"Fibrocytes from burn patients regulate the activities of fibroblasts","volume":"15","author":"JF Wang","year":"2007","journal-title":"Wound Repair Regen"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1067-1927.2005.130407.x","article-title":"Identification of fibrocytes in postburn hypertrophic scar","volume":"13","author":"L Yang","year":"2005","journal-title":"Wound Repair Regen"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00403-012-1225-5","article-title":"Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring","volume":"304","author":"SA Iqbal","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e7475","DOI":"10.1371\/journal.pone.0007475","article-title":"Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts","volume":"4","author":"D Pilling","year":"2009","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JB.181.3.923-933.1999","article-title":"Gene duplication and multiplicity of collagenases in Clostridium histolyticum","volume":"181","author":"O Matsushita","year":"1999","journal-title":"J Bacteriol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0363-5023(96)80368-6","article-title":"Collagenase in the treatment of Dupuytren\u2019s disease: an in vitro study","volume":"21","author":"KD Starkweather","year":"1996","journal-title":"J Hand Surg Am"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e31430","DOI":"10.1371\/journal.pone.0031430","article-title":"In vitro study of novel collagenase (XIAFLEX(R)) on Dupuytren\u2019s disease fibroblasts displays unique drug related properties","volume":"7","author":"F Syed","year":"2012","journal-title":"PloS one"},{"key":"ref33","first-page":"119","article-title":"Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum","volume":"32","author":"MB Pepys","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/TCRM.S8591","article-title":"The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease","volume":"6","author":"A Thomas","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","article-title":"Fibrocytes in health and disease","volume":"38","author":"EL Herzog","year":"2010","journal-title":"Exp Hematol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.biocel.2009.10.014","article-title":"Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis","volume":"42","author":"EC Keeley","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2990","article-title":"Fibrocytes: emerging effector cells in chronic inflammation","volume":"11","author":"RA Reilkoff","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"RJ Phillips","year":"2004","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.ki.5002325","article-title":"Fibrocytes: a new insight into kidney fibrosis","volume":"72","author":"T Wada","year":"2007","journal-title":"Kidney Int"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11926-006-0055-x","article-title":"The role of circulating fibrocytes in fibrosis","volume":"8","author":"TE Quan","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1042\/bst0250520","article-title":"Peripheral blood fibrocytes: novel fibroblast-like cells that present antigen and mediate tissue repair","volume":"25","author":"J Chesney","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","article-title":"The different characteristics of Dupuytren\u2019s disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1","volume":"28","author":"MA Bisson","year":"2003","journal-title":"J Hand Surg Br"},{"key":"ref43","first-page":"890","article-title":"MRP8\/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8\/14 and increased expression of adhesion molecules following renal transplantation","volume":"27","author":"K Burkhardt","year":"1995","journal-title":"Transplant Proc"},{"key":"ref44","first-page":"338","article-title":"Current concept of the role of monocytes\/macrophages in inflammatory bowel disease-balance of proinflammatory and immunosuppressive mediators","volume":"30","author":"N Lugering","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"L341","DOI":"10.1152\/ajplung.00122.2010","article-title":"New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2\/CCR2 axis","volume":"300","author":"L Sun","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1189\/jlb.0507306","article-title":"Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes","volume":"82","author":"J Wang","year":"2007","journal-title":"J Leukoc Biol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0339113","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T05:15:19Z","timestamp":1689311719000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099967"}},"subtitle":[],"editor":[{"given":"Gernot","family":"Zissel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,16]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099967","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,16]]}}}